市場調查報告書

全球動物用醫藥品市場:成長,趨勢,及預測(2020年∼2025年)

Veterinary Drugs Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 921918
出版日期 內容資訊 英文 115 Pages
商品交期: 2-3個工作天內
價格
全球動物用醫藥品市場:成長,趨勢,及預測(2020年∼2025年) Veterinary Drugs Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 115 Pages
簡介

全球動物用醫藥品市場在預測期間內預計將以5.8%的年複合成長率成長。成本效益高的先進動物用醫藥品的存在,和臨床動物研究的增加,是該市場的重要推動要素。還有在該市場中寄生蟲驅除劑是成長快速的部門,感染疾病的盛行率上升,寵物擁有的增加等為成長要素。

本報告提供全球動物用醫藥品市場的相關調查,市場機會和趨勢,成長及阻礙因素,各產品類型、給藥途徑、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 感染疾病的盛行率上升
    • 尤其是生技藥品中新技術的出現
  • 市場阻礙因素
    • 動物疾病相關的複雜的併發症
  • 波特的五力分析

第5章 市場區隔

  • 各產品類型
    • 抗感染藥
    • 抗發炎
    • 寄生蟲驅除劑
    • 疫苗
    • 其他
  • 各給藥途徑
    • 口服
    • 非口服
    • 局部
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Bayer AG
    • Zoetis
    • Virbac SA
    • Boehringer Ingelheim International GmbH (Merial)
    • Elanco
    • Ceva
    • Vetoquinol SA
    • Bimeda, Inc
    • Merck & Co., Inc.,
    • Intervet Inc

第7章 市場機會及今後趨勢

目錄
Product Code: 67648

Market Overview

The veterinary drugs market is expected to register a CAGR of 5.8% during the forecast period. Veterinary drugs are used in the treatment of numerous diseases growing in animals. Veterinary drugs such as antibiotics, antimicrobials, antihistamines, antiprotozoals, and hormones are developed in order to minimize the attack of harmful viruses and bacterial parasites in animals. According to the American Pet Products Association (APPA), 67% percent of United States households own a pet and estimated that 78 million dogs and 85.8 million cats are owned in the United States. The presence of advanced cost-effective veterinary drugs and rising clinical animal researches are the key driving factors in the veterinary drugs market.

Scope of the Report

As per the scope of the report veterinary drugs are used in the treatment of numerous diseases growing in animals. Veterinary drugs such as antibiotics, antimicrobials, antihistamines, antiprotozoals, and hormones are developed in order to minimize the attack of harmful viruses and bacterial parasites in animals. The veterinary drugs market is segmented by Product Type, By Route of Administration and Geography.

Key Market Trends

Parasiticides Segment is Expected to Be the Fastest-Growing Segment

  • Parasites are organisms that survive by attacking pets and farm animals for nourishment and live in or on the body, benefiting from food and protection. Common parasites such as ticks, mosquitos, and fleas live outside the body on the skin or hidden in an animal's fur which not only harms the animal, they can quickly spread a disease outbreak. For instance, the Rift Valley Fever is an endemic zoonotic disease in Africa and the Middle East that costs producers USD 427 million every year.
  • According to the American Pet Products Association (APPA), 67% percent of United States households own a pet and estimated that 78 million dogs and 85.8 million cats are owned in the United States.
  • In the year 2017, parasiticides hold a significant market share and are anticipated to show a similar trend over the forecast period.
  • Due to the rise in the prevalence of infectious diseases and an increase in pet ownership are the key driving factors in the parasiticides segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America expected to hold a major market share in the global veterinary drugs market due to a rise in the prevalence of infectious diseases and the emergence of new technologies in this region. In the year 2017, North America held the highest share and is also expected to continue dominating the market through the forecast period. Moreover, the introduction of new animal-related products and increasing adoption of animals is fueling the growth of the overall regional market to a large extent.

Competitive Landscape

The veterinary drugs market is consolidated competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Bayer AG, Zoetis Animal Healthcare, Virbac S.A, Boehringer Ingelheim International GmbH, Ceva, Vetoquinol S.A, Merck Ltd, Elanco, Intervet Inc, and Bimeda, Inc

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Prevalence of Infectious Diseases
    • 4.2.2 Emergence of New Technologies, especially in Biologics
  • 4.3 Market Restraints
    • 4.3.1 Complex Complications Involved in the Diseases of Animal
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Anti-infectives
    • 5.1.2 Anti-inflammatory
    • 5.1.3 Parasiticides
    • 5.1.4 Vaccines
    • 5.1.5 Others
  • 5.2 By Route of Administration
    • 5.2.1 Oral
    • 5.2.2 Parenteral
    • 5.2.3 Topical
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Bayer AG
    • 6.1.2 Zoetis
    • 6.1.3 Virbac S.A
    • 6.1.4 Boehringer Ingelheim International GmbH (Merial)
    • 6.1.5 Elanco
    • 6.1.6 Ceva
    • 6.1.7 Vetoquinol S.A
    • 6.1.8 Bimeda, Inc
    • 6.1.9 Merck & Co., Inc.,
    • 6.1.10 Intervet Inc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS